Target intelligence / Profile preview

Hepatitis C virus non-structural protein NS4B (NS4B)

Target
NS4B
Molecular classification
Enzyme, Viral non-structural protein, Integral membrane protein, NTPase, RNA-binding protein
01

Overview

Hepatitis C virus non-structural protein NS4B is a 27 kDa hydrophobic integral membrane protein that plays a central role in the viral replication cycle. Its primary function is the induction of the "membranous web," a specialized intracellular structure derived from the endoplasmic reticulum that serves as a protected scaffold for the viral replication complex. Beyond its structural role, NS4B possesses intrinsic enzymatic activities, including NTPase (GTPase and ATPase) functions and RNA-binding capabilities, both of which are essential for efficient viral genome synthesis. NS4B also interacts with host cell pathways, such as the unfolded protein response (UPR) and ER stress signaling, to create an environment conducive to viral persistence. Although most currently approved direct-acting antivirals (DAAs) target the NS3 protease or NS5A/NS5B proteins, NS4B remains a significant therapeutic target due to its essential role in organizing the replication machinery. Experimental inhibitors like clemizole have demonstrated the potential to disrupt NS4B-RNA interactions, offering a distinct mechanism for inhibiting viral replication and overcoming resistance to other DAA classes.

Other names
NS4BNon-structural protein 4Bp27HCV NS4B
02

Mechanism of action

Inhibition of viral RNA binding to NS4B, disruption of the membranous web replication platform, and inhibition of NTPase-mediated viral replication.

03

Biological functions

Membranous web formationViral RNA replicationNTP hydrolysis (GTPase and ATPase activity)RNA bindingEndoplasmic reticulum stress inductionUnfolded protein response (UPR) modulationProtein-protein interaction (recruitment of NS5A and NS3)NS5A hyperphosphorylation modulation
04

Disease associations

Hepatitis C infectionLiver cirrhosisHepatocellular carcinomaSteatosis
05

Safety considerations

Rapid emergence of viral resistance mutationsHigh hydrophobicity complicating drug delivery and solubilityPotential for off-target effects on host ER stress pathwaysGenotype-specific variability in inhibitor efficacy
06

Interacting drugs

Clemizole

3 more in the full profile.

07

Biomarkers

Hepatitis C virus RNA (viral load)Alanine aminotransferase (ALT)Aspartate aminotransferase (AST)Glucose-regulated protein 78 (GRP78)MicroRNA-122 (miR-122)

Beyond the preview

Go deeper on Hepatitis C virus non-structural protein NS4B (NS4B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatitis C virus non-structural protein NS4B (NS4B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call